Free Chat Friday (Every Friday) -- Our live chat room with stock and option alerts! Fridays, starting at 9:30 am,
go to: http://getstockideas.webinato.com/room1 use the password: freechatfriday

Soligenix, Inc.
(NASDAQ : SNGX)

( )
SNGX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
0.79%83.270.9%$976.48m
KITEKite Pharma, Inc.
-0.05%179.3016.1%$742.08m
CELGCelgene Corporation
0.08%143.891.1%$497.73m
AMGNAmgen Inc.
-0.47%185.761.1%$483.16m
BIIBBiogen Inc.
1.09%318.461.2%$422.36m
REGNRegeneron Pharmaceuticals, Inc.
-0.17%432.722.7%$354.34m
ALNYAlnylam Pharmaceuticals, Inc
0.78%113.8010.7%$245.72m
JUNOJuno Therapeutics, Inc.
8.46%45.1414.6%$236.75m
ALXNAlexion Pharmaceuticals, Inc.
-0.07%142.821.9%$228.97m
VRTXVertex Pharmaceuticals Incorporated
-0.53%151.261.9%$211.37m
INCYIncyte Corporation
-3.65%110.852.6%$207.65m
ILMNIllumina, Inc.
0.58%201.413.5%$159.41m
BLUEBluebird Bio, Inc.
0.70%128.7519.3%$141.45m
BMRNBioMarin Pharmaceutical Inc.
1.64%94.954.4%$137.39m
CLVSClovis Oncology, Inc.
2.09%78.5618.0%$136.44m

Company Profile

Soligenix, Inc. is a clinical stage biopharmaceutical company, which engages in developing products to treat serious gastrointestinal diseases. It operates through the BioTherapeutics and Vaccines or BioDefense segments. The BioTherapeutics segment involves in the development of photodynamic therapy (SGX301) utilizing topical synthetic hypericin activated with safe visible light for the treatment of cutaneous T-cell lymphoma. The Vaccines or BioDefense segment includes active development programs for RiVax, ricin toxin vaccine candidate, OrbeShield, GI acute radiation syndrome therapeutic candidate, and SGX943, melioidosis therapeutic candidate. The company was founded in 1987 and is headquartered Princeton, NJ.